Yufeng Zhang Selected Research

Therapeutics

8/2022	Combination of Nd:YAG and Er:YAG lasers in non-surgical periodontal therapy: a systematic review of randomized clinical studies.
5/2022	The current management and biomarkers of immunotherapy in advanced gastric cancer.
1/2022	Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis.
8/2021	Dynamic nomograms combining N classification with ratio-based nodal classifications to predict long-term survival for patients with lung adenocarcinoma after surgery: a SEER population-based study.
1/2021	An electroporation strategy to synthesize the membrane-coated nanoparticles for enhanced anti-inflammation therapy in bone infection.
1/2021	Efficacy and Safety of Regorafenib Combined with Toripalimab in the Third-Line and beyond Treatment of Advanced Colorectal Cancer.
12/2020	Fe-TCPP@CS nanoparticles as photodynamic and photothermal agents for efficient antimicrobial therapy.
5/2020	Bismuth Porphyrin Antagonizes Cisplatin-Induced Nephrotoxicity via Unexpected Metallothionein-Independent Mechanisms.
1/2020	Hsa_circ_0046263 functions as a ceRNA to promote nasopharyngeal carcinoma progression by upregulating IGFBP3.
1/2020	Dual Functional Monocytes Modulate Bactericidal and Anti-Inflammation Process for Severe Osteomyelitis Treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yufeng Zhang Research Topics

Disease

25	Neoplasms (Cancer) 05/2022 - 12/2002
22	Inflammation (Inflammations) 01/2022 - 01/2011
14	Infections 01/2022 - 01/2017
11	Bacterial Infections (Bacterial Infection) 01/2022 - 06/2016
7	Osteoporosis 05/2022 - 11/2013
5	Hypoxia (Hypoxemia) 10/2022 - 11/2004
5	Hypertension (High Blood Pressure) 02/2020 - 11/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2014
4	Wounds and Injuries (Trauma) 01/2022 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 05/2019
4	Alzheimer Disease (Alzheimer's Disease) 04/2020 - 03/2007
4	Hemorrhage 12/2019 - 07/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 05/2019 - 01/2012
4	Ischemia 01/2017 - 06/2011
3	Periodontitis 08/2022 - 04/2016
3	Stroke (Strokes) 06/2022 - 06/2008
3	Heart Failure 01/2022 - 11/2013
3	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2020
3	Critical Illness (Critically Ill) 01/2022 - 01/2020
3	Fever (Fevers) 09/2021 - 08/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 04/2011
3	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2014
3	Atrial Fibrillation 01/2020 - 12/2016
3	Breast Neoplasms (Breast Cancer) 07/2014 - 12/2002
3	Bone Resorption 01/2014 - 08/2013
2	Parkinson Disease (Parkinson's Disease) 06/2022 - 06/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Ulcerative Colitis 01/2022 - 01/2021
2	Nasopharyngeal Carcinoma 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 04/2021 - 11/2019
2	Osteosarcoma (Osteogenic Sarcoma) 04/2021 - 01/2021
2	Carcinogenesis 03/2021 - 01/2020
2	Hypersensitivity (Allergy) 01/2021 - 09/2013
2	Pain (Aches) 01/2021 - 11/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 10/2014
2	Reperfusion Injury 01/2021 - 04/2005
2	Cardiogenic Shock 01/2021 - 01/2020
2	Myocardial Infarction 11/2020 - 12/2010
2	Hypertrophy 01/2017 - 04/2015

Drug/Important Bio-Agent (IBA)

11	Pharmaceutical PreparationsIBA 01/2022 - 11/2018
10	Proteins (Proteins, Gene)FDA Link 09/2022 - 03/2007
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2016
6	Biocompatible Materials (Biomaterials)IBA 01/2022 - 11/2013
6	Therapeutic UsesIBA 01/2021 - 04/2013
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021 - 10/2014
4	AntioxidantsIBA 01/2022 - 04/2005
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 06/2018
3	salicylhydroxamic acid (SHAM)IBA 06/2022 - 09/2013
3	Biological ProductsIBA 06/2022 - 01/2018
3	Immune Checkpoint InhibitorsIBA 05/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 12/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 05/2007
3	EnzymesIBA 04/2021 - 04/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 11/2019
3	CytokinesIBA 01/2020 - 11/2004
3	IonsIBA 11/2019 - 11/2013
2	Oxygen (Dioxygen)IBA 10/2022 - 11/2020
2	Neuroprotective AgentsIBA 06/2022 - 01/2021
2	CurcuminIBA 06/2022 - 12/2019
2	Competitive Endogenous RNAIBA 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	Circular RNAIBA 01/2022 - 01/2020
2	NitrogenIBA 01/2022 - 10/2014
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 10/2014
2	CreatinineIBA 01/2022 - 10/2014
2	Long Noncoding RNAIBA 06/2021 - 09/2019
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 04/2005
2	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2014
2	Simvastatin (Zocor)FDA LinkGeneric 01/2021 - 05/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	Anti-Infective Agents (Microbicides)IBA 12/2020 - 09/2019
2	Peptides (Polypeptides)IBA 02/2020 - 02/2012
2	AlbuminsIBA 01/2020 - 10/2014
2	GoldIBA 01/2020 - 11/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 11/2004
2	Capsules (Microcapsules)IBA 01/2020 - 11/2019
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 01/2019
2	Histone MethyltransferasesIBA 01/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2007
2	strontium ranelate (protelos)IBA 01/2017 - 11/2013
2	Vancomycin FDA LinkGeneric 01/2017 - 01/2017
2	AlkaloidsIBA 03/2016 - 07/2015
2	veratramineIBA 03/2016 - 07/2015
2	Alanine Transaminase (SGPT)IBA 08/2015 - 10/2014
2	Prothrombin (Factor II)IBA 01/2015 - 10/2014
2	BilirubinIBA 01/2015 - 10/2014
2	StrontiumIBA 01/2014 - 11/2013

Therapy/Procedure

15	Therapeutics 08/2022 - 03/2007
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2020 - 05/2013
3	Immunotherapy 05/2022 - 04/2014
3	Radiotherapy 01/2021 - 04/2014
3	Injections 01/2020 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2018 - 11/2013
3	Ligation 04/2016 - 12/2010
2	Aftercare (After-Treatment) 01/2022 - 01/2018
2	Oral Administration 01/2021 - 02/2012
2	Critical Care (Surgical Intensive Care) 01/2021 - 01/2020
2	Length of Stay 12/2019 - 12/2016
2	Bone Transplantation (Bone Grafting) 05/2018 - 07/2012